JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(1):17-20

The influence of the extrusion die on pellet characteristics

M. Rabišková, D. Weingartová, A. Häring
Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic

Characteristics of pellets (pellet size distribution, their mean diameter, density, hardness, friability, repose angle, Hausner ratio, and drug dissolution profiles) prepared by axial and radial extrusion/spheronization were examined in this experimental study. The formulation consisted of binary mixtures of theophylline, a drug slightly soluble in water, and Avicel® CL 611 as an excipient. Different characteristics were found in the samples prepared using the different extrusion dies: the axially situated extrusion die produces the pellets of higher hardness and density, and slower dissolution profiles. Differences in drug dissolution profiles should be considered, nevertheless they are not significant. All pellet samples showed low friability and excellent flow properties.

Keywords: pellets; theophylline; Avicel® CL 611; extrusion, spheronization; axial extrusion; radial extrusion

Received: November 21, 2006; Accepted: December 18, 2006; Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rabišková M, Weingartová D, Häring A. The influence of the extrusion die on pellet characteristics. Čes. slov. farm. 2007;56(1):17-20.
Download citation

References

  1. Ghandi, R., Lal Kaul, Ch., Panchagnula, R.: Pharm. Sc.i Technol. Today, 1999; 2, 160-170. Go to original source... Go to PubMed...
  2. Ghebre-Sellassie, I.: Pharmaceutical Pelletization Technology. New York and Basel, Marcel Dekker, 1989, 274 s.
  3. Vervaet, Ch., Baert, L., Remon, J. P.: Int. J. Pharm., 1995; 116, 131-146. Go to original source...
  4. Peréz J-P., Rabišková M.: Int. J. Pharm. 2002; 242, 349351. Go to original source... Go to PubMed...
  5. http://www.fmcbiopolymers.com 16.11.2006
  6. Kim, H.; Fassihi, R.: J. Pharm. Sci. 1997; 86, 323-328. Go to original source... Go to PubMed...
  7. Hasznos, L., Langer, I., Gyarmathy, M.: Drug Dev. Ind. Pharm., 1992; 18, 409-437. Go to original source...
  8. Krejčová, K., Rabišková, M., Vetchý, D. et al.: Drug Dev. Ind. Pharm., 2006; 32, 585-593. Go to original source... Go to PubMed...
  9. Swarbrick, J., Boylan, J. C.: Encyclopedia of Pharmaceutical Technology, Volume 6. New York and Basel, Marcel Dekker Inc., 1996, 489 s. 20 ČESKÁ A SLOVENSKÁ FARMACIE, 2007, 56, č. 1




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.